Mystic Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.05M Buy
179,704
+28
+0% +$745 1.17% 20
2025
Q4
$4.47M Sell
179,676
-39,546
-18% -$997K 1.01% 24
2025
Q3
$5.59M Buy
219,222
+116
+0.1% +$2.86K 1.26% 18
2025
Q2
$5.31M Buy
219,106
+33,970
+18% +$792K 1.28% 16
2025
Q1
$4.69M Buy
185,136
+11,130
+6% +$291K 1.24% 19
2024
Q4
$4.62M Buy
174,006
+97,231
+127% +$2.64M 1.24% 15
2024
Q3
$2.22M Buy
76,775
+504
+0.7% +$14.7K 0.84% 33
2024
Q2
$2.13M Sell
76,271
-767
-1% -$21.1K 0.86% 31
2024
Q1
$2.14M Buy
77,038
+1,200
+2% +$33.3K 0.88% 28
2023
Q4
$2.18M Buy
75,838
+1,717
+2% +$51.9K 1.04% 27
2023
Q3
$2.46M Sell
74,121
-905
-1% -$32K 1.38% 21
2023
Q2
$2.75M Hold
75,026
1.48% 18
2023
Q1
$3.06M Sell
75,026
-343
-0.5% -$14.8K 1.69% 13
2022
Q4
$3.86M Buy
75,369
+53
+0.1% +$2.54K 2.2% 5
2022
Q3
$3.29M Buy
75,316
+85
+0.1% +$4.13K 2.11% 5
2022
Q2
$3.94M Buy
75,231
+1,350
+2% +$68.8K 2.41% 5
2022
Q1
$3.82M Sell
73,881
-1,740
-2% -$90.3K 2.06% 6
2021
Q4
$4.46M Buy
+75,621
New +$3.75M 2.11% 5

Other funds holding PFE

Mystic Asset Management's PFE Position: Q1 2026 in Review

Mystic Asset Management increased its Pfizer (PFE) stake by 0.02% in Q1 2026, buying an estimated $745 and bringing the position to 179,704 shares worth $5.05M. The position accounts for 1.17% of the portfolio, ranked #20.

Mystic Asset Management first reported a position in PFE in Q4 2021 and has held it in 18 quarters since. The position peaked at $5.59M in Q3 2025. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Mystic Asset Management held 179,704 shares of Pfizer worth $5.05M as of Q1 2026.
  • Mystic Asset Management bought 28 Pfizer shares in Q1 2026, an estimated $745.
  • Pfizer made up 1.17% of Mystic Asset Management's portfolio in Q1 2026, its #20 holding.
  • Mystic Asset Management first reported a position in Pfizer in Q4 2021 and has held it in 18 quarters since.
  • Mystic Asset Management's Pfizer position peaked at $5.59M in Q3 2025.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Mystic Asset Management's 13F filing for Q1 2026, filed 8 May 2026.